This product is indicated for the treatment of major depressive disorder.
1. For the treatment of partial seizures (with or without secondary general seizures) in adults and children over 4 years of age.
2. For the treatment of generalized tonic-clonic seizures in adults and adolescents over 16 years of age.
This product is indicated for the treatment of: · Postherpetic neuralgia · Fibromyalgia · Adjunctive therapy for partial onset seizures in adults
1. Major depressive disorder (MDD) 2. Obsessive-compulsive disorder (OCD) 3. Panic disorder (PD) 4. Posttraumatic stress disorder (PTSD) 5. Social anxiety disorder (SAD) 6. Premenstrual dysphoric disorder (PMDD)
This product is an atypical antipsychotic indicated for the treatment of: 1. Schizophrenia in adults and adolescents (13 to 17 years) 2. Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients (10 to 17 years) as monotherapy 3.Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults as adjunctive therapy with lithium or valproate
